A carregar cotações...

Previsão

O preço-alvo médio dos analistas é € 30,16 (-3,64%). A mediana é € 28,12 (-10,16%).

Comprar
  8
Manter
  7
Vender
  0

Discussões na comunidade

Ainda não há nenhuma discussão sobre este ativo.

Iniciar discussão

  • Double downgrade drives Trupanion stock sharply lower

    The stock of Trupanion fell about 6.4% in morning trading after Piper Sandler cut its rating from "Overweight" to "Neutral" and lowered the price target from $45 to $32. Piper Sandler cited declining puppy vet visits and more costly, aging COVID cohorts as headwinds for premium growth and underwriting margins. A simultaneous downgrade by Zacks intensified the sell-off, while the new price target, near the current share price, signals only limited short-term upside. » Mais em de.investing.com


  • Trupanion beats Q2 earnings forecast and highlights outlook for 2026

    Trupanion reported Q2/2026 earnings of $0.16 per share, beating the $0.1133 forecast, on revenue up 11% to $392.9m. Adjusted operating income from subscriptions rose 24% and subscription revenue grew 14% to $276.7m, while the number of insured pets increased 5% to 1.125m. The stock rose 6.7% after hours; management confirmed a 2026 revenue range of $1.584–1.601bn and adjusted operating income of $176–184m. Risks remain higher customer acquisition costs, ongoing veterinary price inflation and execution risks for new product options. » Mais em de.investing.com


  • Trupanion reaches 52-week low at $24.13

    Trupanion shares fell to a 52-week low of $24.13 after losing about 34% over the past year and roughly 40% in recent months. For Q4 2025 the company reported earnings per share of $0.13 (forecast $0.16) and revenue of $376.9 million (+12% year over year), slightly beating expectations. Analysts cut price targets (Cantor Fitzgerald 42→34 USD, Stifel 35→31 USD) citing growth and scaling concerns, while InvestingPro signaled possible undervaluation and upside; Trupanion also announced a research collaboration with the Human Animal Bond Research Institute. » Mais em de.investing.com


  • Trupanion falls to 52-week low of $24.30

    Trupanion shares hit a new 52-week low at $24.30, down about 31.7% year-to-date; the six-month performance is down nearly 38%. The company reported Q4 2025 EPS of $0.13 (expectation $0.16) on revenue of $376.9 million (+12% YoY, forecast $375.21 million). Analysts cut price targets (Cantor Fitzgerald 42 → 34 USD, Stifel 35 → 31 USD), citing growth and scaling issues, while InvestingPro sees an undervaluation of around 38% and expects profitability this year. Trupanion also announced a partnership with the Human Animal Bond Research Institute to support studies on human-animal relationships. » Mais em de.investing.com


  • Trupanion hits 52-week low after sharp share decline

    Trupanion shares closed at $24.49, marking a 52-week low after declines of 33.06% over the past year, 43% in six months and 31% year-to-date. Investors are worried about slowing growth and competitive pressure in the pet insurance industry, although a PEG of 0.19 suggests possible undervaluation. In Q4 2025, Trupanion missed the EPS expectation (0.13 vs. $0.16) while revenue rose 12% to $376.9 million; a partnership with the Human Animal Bond Research Institute was also announced. » Mais em de.investing.com

Em 2022, Trupanion já distribuiu € 0,0078 em dividendos. A última distribuição ocorreu em abril de 2022.

Dados financeiros da empresa

No último trimestre, Trupanion registou receitas de € 358,08 mi e um ganho líquido de € 8,19 mi
(EUR) setembro de 2026
YoY
Receitas 358,08 mi 14,52%
Ganho bruto 61,36 mi 19,90%
Ganho líquido 8,19 mi 63,74%
EBITDA 14,03 mi 22,48%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 1,35 bi
Número de ações
43,27 mi
Máximo/mínimo de 52 semanas
€ 35,26 - € 19,20
Dividendos Não
Beta
1,30
PER (PE Ratio)
56,52
PEG (PEG Ratio)
0,76
P/VC (PB Ratio)
3,77
P/V (PS Ratio)
0,96

Perfil da empresa

A Trupanion, Inc., juntamente com as suas subsidiárias, oferece seguros de saúde para gatos e cães, com base em subscrição mensal, nos Estados Unidos, no Canadá, em Porto Rico e na Austrália. A empresa opera em dois segmentos, Subscription Business e Other Business. Dirige-se a donos de animais de estimação e a médicos veterinários. A empresa era anteriormente conhecida como Vetinsurance International, Inc. e mudou o seu nome para Trupanion, Inc. em 2013. A empresa foi fundada em 2000 e tem sede em Seattle, Washington.

Nome
Trupanion
CEO
Margaret Rosemary Maria Tooth
Sede Seattle, wa
EUA
Site
Setor
Finanças
Indústria
Seguros
Entrada em bolsa
18/07/2014
Colaboradores 1.121

Símbolos de ticker

Bolsa Símbolo
NASDAQ
TRUP
London Stock Exchange
0LH0.L
Frankfurt
TPW.F
Düsseldorf
TPW.DU
London
0LH0.L
SIX
TPW.SW
München
TPW.MU
🍪

Parqet  utiliza cookies. Saber mais